Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled intervention trial involving 100 treated
subjects undergoing endonasal trans-sphenoidal (ENTS) resection of pituitary lesion. Subjects
will be randomized into two groups: 50 treated in the opioid-sparing arm and 50 treated in
the standard post-operative medication arm.